rs13361707, PRKAA1

N. diseases: 7
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Neoplasms
CUI: C0027651
Disease: Neoplasms
0.010 GeneticVariation BEFREE Our meta-analysis showed that AMPK pathway had significant associations with progression-free survival (PFS; p < 0.001) and overall survival (OS; p < 0.001), but not with tumor response (TR; p = 0.220): PRKAA1 rs13361707 was significantly associated with favorable PFS (log HR = -0.219, SE = 0.073, p = 0.003), as well as PRKAA1 rs10074991 (log HR = -0.215, SE = 0.073, p = 0.003), and there were suggestive associations of PRKAG1 rs1138908 with unfavorable OS (log HR = 0.170, SE = 0.083, p = 0.041), and of UBE2O rs3803739 with unfavorable PFS (log HR = 0.137, SE = 0.068, p = 0.042) and OS (log HR = 0.210, SE = 0.077, p = 0.006), although these results were not significant after false discovery rate adjustment. 30856283 2019
Intestinal metaplasia
CUI: C0334037
Disease: Intestinal metaplasia
0.010 GeneticVariation BEFREE Moreover, three SNPs, MUC1 rs4072037, ZBTB20 rs9841504 and PRKAA1 rs13361707, were associated with precancerous gastric lesions (severe IM/dysplasia). 28220687 2017
Malignant Neoplasms
CUI: C0006826
Disease: Malignant Neoplasms
0.020 GeneticVariation BEFREE To sum up, PRKAA1 rs13361707 polymorphism is not participant with the increased risk of cancer, while the A allele of PRKAA1 rs10074991 revealed a significant decrease risk. 30340465 2018
Primary malignant neoplasm
CUI: C1306459
Disease: Primary malignant neoplasm
0.020 GeneticVariation BEFREE To sum up, PRKAA1 rs13361707 polymorphism is not participant with the increased risk of cancer, while the A allele of PRKAA1 rs10074991 revealed a significant decrease risk. 30340465 2018
Malignant Neoplasms
CUI: C0006826
Disease: Malignant Neoplasms
0.020 GeneticVariation BEFREE Also those with a hereditary background including the risk alleles PLCE1 rs2274223 and PTGER4/PRKAA1 rs13361707 were 3 times more susceptible to cardia cancer than those without. 27127881 2016
Primary malignant neoplasm
CUI: C1306459
Disease: Primary malignant neoplasm
0.020 GeneticVariation BEFREE Also those with a hereditary background including the risk alleles PLCE1 rs2274223 and PTGER4/PRKAA1 rs13361707 were 3 times more susceptible to cardia cancer than those without. 27127881 2016
Schizophrenia
CUI: C0036341
Disease: Schizophrenia
0.700 GeneticVariation GWASDB Common variants on 8p12 and 1q24.2 confer risk of schizophrenia. 22037555 2011
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.780 GeneticVariation BEFREE TLR1 rs4833095 SNP was associated with an increased risk of GC in a European population, while PRKAA1 rs13361707 genetic variant was not linked with GC. 30574617 2018
Malignant neoplasm of stomach
CUI: C0024623
Disease: Malignant neoplasm of stomach
0.780 GeneticVariation BEFREE In similar, an increased risk of gastric cancer was also observed for rs13361707</span> TC genotype (adjusted OR = 1.47, 95%CI: 1.01-2.14, p = 0.043; additive model: adjusted OR = 1.22, 95%CI: 1.02-1.47, p = 0.033). 30253744 2018
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.780 GeneticVariation BEFREE The meta-analysis reveals that the PRKAA1 rs13361707 T>C polymorphism has a significant relationship with increased GC risk. 29620653 2018
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.780 GeneticVariation GWASCAT Genome-wide association study identifies gastric cancer susceptibility loci at 12q24.11-12 and 20q11.21. 30281874 2018
Malignant neoplasm of stomach
CUI: C0024623
Disease: Malignant neoplasm of stomach
0.780 GeneticVariation BEFREE TLR1 rs4833095 SNP was associated with an increased risk of GC in a European population, while PRKAA1 rs13361707 genetic variant was not linked with GC. 30574617 2018
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.780 GeneticVariation BEFREE In similar, an increased risk of gastric cancer was also observed for rs13361707</span> TC genotype (adjusted OR = 1.47, 95%CI: 1.01-2.14, p = 0.043; additive model: adjusted OR = 1.22, 95%CI: 1.02-1.47, p = 0.033). 30253744 2018
Malignant neoplasm of stomach
CUI: C0024623
Disease: Malignant neoplasm of stomach
0.780 GeneticVariation BEFREE The meta-analysis reveals that the PRKAA1 rs13361707 T>C polymorphism has a significant relationship with increased GC risk. 29620653 2018
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.780 GeneticVariation BEFREE Correlation between protein kinase catalytic subunit alpha-1 gene rs13361707 polymorphism and gastric cancer susceptibility in asian populations. 28978122 2017
Malignant neoplasm of stomach
CUI: C0024623
Disease: Malignant neoplasm of stomach
0.780 GeneticVariation BEFREE Correlation between protein kinase catalytic subunit alpha-1 gene rs13361707 polymorphism and gastric cancer susceptibility in asian populations. 28978122 2017
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.780 GeneticVariation GWASCAT Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies. 26701879 2017
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.780 GeneticVariation BEFREE In summary, these results indicated that the C allele of PRKAA1 rs13361707 was a low-penetrate risk factor for GCa. 26485766 2015
Malignant neoplasm of stomach
CUI: C0024623
Disease: Malignant neoplasm of stomach
0.780 GeneticVariation BEFREE In summary, these results indicated that the C allele of PRKAA1 rs13361707 was a low-penetrate risk factor for GCa. 26485766 2015
Malignant neoplasm of stomach
CUI: C0024623
Disease: Malignant neoplasm of stomach
0.780 GeneticVariation BEFREE In the dominant model, SNPs rs13361707 [odds ratio (OR) = 1.51, 95%CI: 1.07-2.11)], rs154268 (OR = 1.65, 95%CI: 1.22-2.22), rs6882903 (OR = 1.48, 95%CI: 1.09-2.00), and rs10074991 (OR = 1.53, 95%CI: 1.09-2.16) were significantly associated with an increased risk of gastric cancer. 25024613 2014
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.780 GeneticVariation BEFREE In the dominant model, SNPs rs13361707 [odds ratio (OR) = 1.51, 95%CI: 1.07-2.11)], rs154268 (OR = 1.65, 95%CI: 1.22-2.22), rs6882903 (OR = 1.48, 95%CI: 1.09-2.00), and rs10074991 (OR = 1.53, 95%CI: 1.09-2.16) were significantly associated with an increased risk of gastric cancer. 25024613 2014
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.780 GeneticVariation BEFREE Our study showed that the rs13361707 polymorphism was associated with increased risk of gastric cancer in a Korean population. 23861218 2013
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
0.780 GeneticVariation BEFREE These findings indicate that the three SNPs (rs4072037, rs13361707 and rs2274223) identified in the GWASs may interact with H. pylori infection to increase the risk of GC. 24069371 2013
Malignant neoplasm of stomach
CUI: C0024623
Disease: Malignant neoplasm of stomach
0.780 GeneticVariation BEFREE These findings indicate that the three SNPs (rs4072037, rs13361707 and rs2274223) identified in the GWASs may interact with H. pylori infection to increase the risk of GC. 24069371 2013
Malignant neoplasm of stomach
CUI: C0024623
Disease: Malignant neoplasm of stomach
0.780 GeneticVariation BEFREE Our study showed that the rs13361707 polymorphism was associated with increased risk of gastric cancer in a Korean population. 23861218 2013